RED CAT HOLDINGS INC (RCAT)
US75644T1007 - Common Stock
We assign a fundamental rating of 3 out of 10 to RCAT. RCAT was compared to 124 industry peers in the Electronic Equipment, Instruments & Components industry. No worries on liquidiy or solvency for RCAT as it has an excellent financial health rating, but there are worries on the profitability. RCAT is valied quite expensively at the moment, while it does show a decent growth rate.
1. Profitability
1.1 Basic Checks
RCAT had negative earnings in the past year.
RCAT had a negative operating cash flow in the past year.
RCAT had negative earnings in each of the past 5 years.
RCAT had a negative operating cash flow in each of the past 5 years.
1.2 Ratios
With a Return On Assets value of -80.78%, RCAT is not doing good in the industry: 91.06% of the companies in the same industry are doing better.
RCAT has a worse Return On Equity (-94.46%) than 85.37% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -80.78% | ||
| ROE | -94.46% | ||
| ROIC | N/A |
ROA(3y)-36.1%
ROA(5y)-55.7%
ROE(3y)-39.94%
ROE(5y)-95.13%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
RCAT's Gross Margin of 16.02% is on the low side compared to the rest of the industry. RCAT is outperformed by 72.36% of its industry peers.
In the last couple of years the Gross Margin of RCAT has remained more or less at the same level.
The Profit Margin and Operating Margin are not available for RCAT so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 16.02% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.21%
GM growth 5YN/A
2. Health
2.1 Basic Checks
RCAT does not have a ROIC to compare to the WACC, probably because it is not profitable.
RCAT has more shares outstanding than it did 1 year ago.
The number of shares outstanding for RCAT has been increased compared to 5 years ago.
RCAT has a better debt/assets ratio than last year.
2.2 Solvency
RCAT has an Altman-Z score of 49.75. This indicates that RCAT is financially healthy and has little risk of bankruptcy at the moment.
RCAT has a better Altman-Z score (49.75) than 99.19% of its industry peers.
There is no outstanding debt for RCAT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 49.75 |
ROIC/WACCN/A
WACC10.01%
2.3 Liquidity
A Current Ratio of 5.08 indicates that RCAT has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 5.08, RCAT belongs to the top of the industry, outperforming 82.11% of the companies in the same industry.
A Quick Ratio of 2.55 indicates that RCAT has no problem at all paying its short term obligations.
Looking at the Quick ratio, with a value of 2.55, RCAT is in the better half of the industry, outperforming 62.60% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 5.08 | ||
| Quick Ratio | 2.55 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an nice 14.81% over the past year.
RCAT shows a strong growth in Revenue. In the last year, the Revenue has grown by 119.36%.
RCAT shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 176.68% yearly.
EPS 1Y (TTM)14.81%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-54.55%
Revenue 1Y (TTM)119.36%
Revenue growth 3Y52.8%
Revenue growth 5Y176.68%
Sales Q2Q%58.83%
3.2 Future
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y61.75%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year117.48%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for RCAT. In the last year negative earnings were reported.
Also next year RCAT is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
RCAT does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
RED CAT HOLDINGS INC
NASDAQ:RCAT (11/20/2024, 8:00:01 PM)
Premarket: 6.99 +0.62 (+9.73%)6.37
+1.63 (+34.39%)
Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap494.12M
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -80.78% | ||
| ROE | -94.46% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 16.02% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.5
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 5.08 | ||
| Quick Ratio | 2.55 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)14.81%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y61.75%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)119.36%
Revenue growth 3Y52.8%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y